Rigel Pharmaceuticals Articles
AstraZeneca presents mixed data on fostamatinib in RA
13 December 2012
AstraZeneca/Rigel’s fostamatinib shows positive response in rheumatoid arthritis in Ph IIb study
22 September 2010
Showing 1-5 of 5 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
